The intervention of Chinese medicine on M1/M2 switch in different diseases.
Abstract
Macrophage polarization is a spectrum of phenotypes and generally can be classified into two states: (1) classically activated or M1 macrophages, which can be driven by lipopolysaccharide (LPS) alone or in association with Th1 cytokines and produce pro-inflammatory cytokines such as TNF-α, IL-6 and, IL-12, and (2) alternatively activated M2 macrophages, which can be promoted by Th2 mediators IL-4 and IL-13 and produce anti-inflammatory cytokines such as TGF-β and IL-10. Current studies have found that the phenotypic switch between M1 and M2 macrophages governs the fate of an organ in inflammation or injury. The imbalance of M1/M2 polarization is closely involved in various pathological processes and is becoming a potential target for therapeutic strategies. Traditional Chinese medicine is an integrated healthcare system composed of many practices and is characterized by multi-target, multi-level, and coordinated intervention effects. Chinese medicines nowadays are applied to regulate phenotype polarization of macrophages to improve the microenvironment, thus ameliorating or even eliminating the symptoms. In this chapter, we will discuss the molecular mechanisms of macrophage polarization, their roles in health and disease, and the intervention with Chinese medicines to modulate the polarization of macrophages in tumor microenvironment (TME) for therapeutic purpose.
Keywords
- tumor microenvironment
- tumor-associated macrophage
- polarization
- Chinese medicine
1. Introduction
Primary and metastatic tumors are generally known as a complex ecosystem containing tumor cells and the surrounding environment, called tumor microenvironment (TME). Apart from autonomous changes by genetic alteration of tumor cells, the dynamic changes of TME progress the tumor progression [1]. TME is a multifaceted pool that consists of various cell types including neoplastic cells, stromal cells, and immune cells that interact with one another via numerous secreted cytokines, growth factors, and chemokines. Tumor-associated macrophages (TAMs) take up a large portion of recruited immune cells and constitute up to 50% of the tumor mass. It was reported that the high level of TAMs is associated with poor prognosis and decreasing overall survival in many cancers, such as liver, breast, gastric, and thyroid cancers, suggesting that TAMs certainly play essential roles during tumor development [2, 3, 4, 5, 6].
TAM recruitment and accumulation are regulated by various cytokines and chemokines, such as CCL2, CCL5, CCL7, CXCL12, etc., and growth factors including VEGF, PDGF, and CSF1, as well as other factors such as fibronectin and fibrinogen [7, 8, 9, 10]. CSF1 is the major regulator for monocyte proliferation and differentiation. CCL2 is a dominant attractant in many tumors. Since monocytes highly expressed the receptor of CCL2 (CCR2), most of tumors produced a high level of CCL2 that can intensely attract monocytes migrating toward CCL2-CCR2 axis [11, 12, 13, 14, 15, 16, 17]. However, CCL2 inhibition studies show that it could not completely suppress TAM accumulation, indicating that other factors affect this process [7, 17, 18, 19, 20, 21]. The CCL12-CXCR4 axis is reported to promote TAM regional accumulation under therapeutic treatments. In mice model, breast cancer highly expressed CCL20 and CCL5; Either inhibited CCL20 expression or treated with CCR5 antagonist, the number of TAMs was significantly reduced within tumors. These studies have shown that in breast cancer, CCL20-CCR6 and CCL5-CCR5 axes contribute to TAM accumulation. Another chemokine CCL11 can be induced under hypoxia condition and subsequently recruit TAMs to the hypoxic region.
In turn, TAMs can produce different molecules to remodel TME and influence fundamental aspects of tumor pathology. For instance, TAMs secrete endothelial growth factor (EGF) to increase neoplastic proliferation directly [22]; TAMs release vascular endothelial growth factors (VEGF) [23], angiogenic factor thymidine phosphorylase, and other chemokines including CCL2 and CXCL8 to enhance angiogenesis; TAMs produce metalloproteases (MMPs) to change TME matrix architecture for tumor metastasis [24]; and TAMs express immune regulatory molecules such as arginase-1 (ARG1), IL-10, and IL12 to modulate immune response [2]. The role of TAMs is accomplished by their phenotypic plasticity, either pro-inflammatory or anti-inflammatory phenotype, in response to the complex stimuli in TME. The double-edged sword feature of TAM polarization makes them as a novel and potent target for cancer prevention and treatments.
Traditional Chinese medicine is an integrated healthcare system composed of many practices that were rooted in China for over 5000 years. Due to its multi-target, multi-level, and coordinated intervention effects, Chinese medicine is widely used for therapeutic strategies. Recent studies reported that some of the Chinese herbal medicines have beneficial effects on cancer therapy via modulating TAM polarization, indicating a new mechanism for Chinese medicine treatment. In this chapter, we will explore the molecular mechanisms of TAM polarization and their roles in health and disease, and we will review the intervention by some of the Chinese herbal medicines on TAM polarization.
2. TAM polarization and molecular mechanisms
2.1 TAM polarization
It is widely accepted that the majority of TAMs are derived from circulating monocytes via cytokine recruitment and then differentiate to macrophages. And those at the metastatic sites are called metastatic-associated macrophages (MAMs) according to their location [25]. While recent studies have shown that the tissue-resident macrophages also contribute to TAM population [26, 27], these progenitors, also called embryonic macrophages, are derived from the yolk sac or fetal liver-derived progenitors, and they can maintain themselves by local proliferation in a hematopoietic system-independent way [28]. The selective depletion studies found that only the tissue-resident macrophages support the established tumor growth. Therefore, TAMs are heterogeneous cell populations from both tissue-resident macrophages and monocyte-derived macrophages and assist TME remodeling.
Besides their heterogeneity, TAMs are also characterized by high plasticity. In the general regard, macrophages can be overgeneralized to two extreme subsets based on the stimuli, surface markers, and secreted molecules, as well as functional properties: the classically activated M1 and alternatively activated M2 macrophages. The M1 phenotype is induced by the Th1 cytokine interferon-γ (IFN-γ), bacterial moieties such as lipopolysaccharide (LPS), and Toll-like receptor (TLR) agonists. The M1 macrophages are characterized by their capacity to produce inflammatory cytokines (e.g., IL-6, IL-1, IL-12, IL-23, and TNF-α) and stimulate immune response, express reactive oxygen species (ROS) and inducible nitric oxide synthase (iNOS), and have a cytotoxic effect toward neoplastic cells and phagocytic microorganisms [29, 30, 31, 32, 33, 34]. Generally, the M1-like macrophages act as sentries and display tumoricidal function, antimicrobial activity, and tissue destruction effect [33, 35].
In contrast, the M2 phenotype is promoted by Th2 mediators and produces immunosuppressive factors (e.g., IL-10, TGF-β) and growth factors (e.g., VEGF) and exerts anti-inflammatory and pro-tumorigenic activities [34, 36, 37]. Moreover, the M2-like macrophages can be further subdivided into three categories, M2a, M2b, and M2c, based on the type of stimuli. The M2a macrophages are driven by type II cytokines including IL4 and IL13 and expressed a high level of arginase-1; M2b macrophages are activated by immune complexes/TLR, while M2c macrophages by anti-inflammatory cytokines (e.g., IL-10) and glucocorticoids [38]. The M2-like macrophages promote angiogenesis, wound repair, and tumor growth, as well as resistance to parasitic infection. Many studies reported that TAMs mostly represent M2-like macrophages and play pro-tumoral roles.
2.2 Molecular mechanisms in regulating TAM polarization
2.2.1 The JNK signaling pathway
The c-Jun N-terminal kinase (JNK) proteins are a group of stress-activated serine threonine protein kinases of the MAPK and can be activated by various external stimuli including inflammatory cytokines, environmental stresses, growth factors, and GPCR agonists. The outside signals can be transduced by small GTPase to MAP3Ks and further activate MKK4/7. The MAP3Ks play key roles in the JNK pathway and affect tremendous downstream transcription factors including AP-1, Smad3, and STAT3, thus controlling many biological processes [39]. The studies on adipose tissue macrophages (ATMs) have demonstrated that the JNK pathway is indispensable in regulating M1/M2 phenotype formation. In HFD-/NAFLD-induced inflammation and obesity, the activated JNK pathway can promote the expression of the M1-associated genes via CCR2 and NF-κB signaling. The M1-like ATMs are related to the resistance to insulin [40, 41]. Recent studies found that normal adipocytes produce Th2 cytokines, such as IL-13 and IL-4 which can enhance M2-like macrophage polarization via activating STAT6 and PPAR𝛿/𝛽, as well as ACE to block the JNK pathway-induced M1-like phenotype [42]. Studies also found that vigorous exercise can promote M2 state through decrease phosphor-JNK [43].
2.2.2 The PI3K/Akt signaling pathway
Among different pathways, the PI3K/Akt pathway is playing a central role in regulating polarized phenotype alteration. It can be activated by many stimuli such as TLR4, PRRs, FcRs, and cytokines and modify downstream cytokine production [44, 45, 46, 47]. In turn, the PI3K/Akt pathway can affect the expression of stimuli and form a feedback loop. For example, the activated PI3K/Akt pathway can inhibit the transcription factors of TLR4 including TRAF6 and FOXO1 either directly or indirectly to suppress TLR4 stimulation. The PI3K has two transducers PIP2 and PIP3 which exert opposite functions during stimulation. It has been reported that PIP2 can enlarge LPS-induced M1-like macrophage polarization, while PIP3 can target mTORC2 via Akt recruitment and promote M2-like macrophage polarization. Other studies found that PTEN and SHIP play an inhibitory effect on PI3K/Akt transduction by transforming PIP3 to PIP2. The downstream signals mTORC1 and mTORC2 also participate in regulating M1/M2 alteration. Deletion of TSC1 can promote LPS-induced M1 polarization and inhibit IL-4-triggered M2 polarization via inhibiting mTORC1-induced Akt signaling, while the deletion of TSC2 gives an opposite response. Furthermore, the isoforms of Akt also contribute to influence the M1-/M2-polarized phenotype transformation in the opposite way. In knocked out Akt1, the expressions of iNOS and IL-12 were enhanced which is a hallmark of M1-like macrophages, and the transcription factor C/EBPβ of M2-related genes was decreased. The deletion of Akt2 led to C/EBPβ and M2 markers enhanced, including Arg1, Fizz1, and Ym1 [48].
2.2.3 The JAK/STAT signaling pathway
The JAK/STAT pathway is one of the principle regulators for transducing different signals and affects various gene expressions. The JAK family consists of JAK1–3 and TYK2 and can be recruited and bind to the intracellular domains of activated receptors. JAKs will subsequently become dimers after autophosphorylation and then phosphorylate their downstream STAT family which has seven members including STAT1–4, STAT5A/B, and STAT6. The activated STAT family will translocate to the nucleus and modulate the expression of their target genes [49]. Increasing evidence found that the JAK/STAT pathway is closely related to M1/M2 phenotypic polarization. Among different stimuli of JAK/STAT signaling pathway, the IFN-γ has been known as a strong inducer of M1 phenotype through STAT1 activation [50]. It is controlled by IRF5 and IRF4 which exert promotive and inhibitory effects, respectively [51]. The IL-4 and IL-10 can activate STAT3 and STAT6 to program the M2-like phenotype and also have cross talk with JNK pathway as mentioned in the JNK signaling pathway. The IL-13 can activate both M1- and M2-associated genes through STAT1, STAT3, and STAT6 activation [52]. There are two regulators of JAK/STAT pathway that affect M1/M2 reprogramming, SOCS1 and SOCS3. The SOCS1 exhibits a suppressive function on STAT1, thus leading to the M1-like phenotype inhibition, while activating STAT6 to induce M2 polarization. The SOCS3 can activate STAT1 activity to contribute M1 polarization [53, 54].
2.2.4 The Notch signaling pathway
The Notch pathway is generally known to play a fundamental role in regulating development and assist to govern the fate in response to different stimuli. There are four members of transmembrane receptors including Notch1–4. When the Notch receptors bind to their ligand family, such as Delta-like proteins (DLLs) and Jagged proteins, the Notch intracellular domain (NICD) receptors will be released into the cell nucleus and binds to RBP-J to form a transcription complex, thus driving the target gene expression [55]. For example, LPS stimulation can upregulate DLL4 which is one of the DLLs in the TLR4/NF-κB-dependent way. The increased DLL4 can lead to activated Notch signaling and induce pro-inflammatory genes, such as IL-12 and iNOS [56]. Apart from the direct function of RBP-J, it can also positively regulate IRF8 activation to promote pro-inflammatory cytokine production. And this regulation is associated with PI3K/Akt and TLR4/NF-κB pathways [57].
2.2.5 Other molecular mechanisms
Apart from the signaling pathways mentioned above, there are many other pathways involving in M1/M2 reprogramming. For example, the TLR/NF-κB pathway is important in regulating the innate immune response. TLRs can sense the microbial components and transduce signals to affect NF-κB activity. When the NF-κB is formed as p50/p65, it promotes M1-associated gene expression, while p50/p50 form has beneficial effects on M2-associated gene expression [58, 59]. It is worth noting that the hypoxia-dependent pathway also participates in M1/M2 phenotypic switch. The HIF-1α is induced under hypoxia condition and serves as a transcription factor to regulate protein production. It has been reported that HIF-1α promotes M1-like polarization by enhancing iNOS production and HIF-2α promotes M2 phenotype via increasing Arg-1 expression [60].
3. Roles of TAM polarization and Chinese medicine intervention
The roles of TAMs under physiological and pathological conditions depend on their dichotomic polarization. Generally, when infection of tissue or damage occurs, The first-responding TAMs show M1-like phenotype and secrete pro-inflammatory cytokines to defend against invading pathogens and eliminate necrotic cells. And at the latter stage, the M2-like macrophages have shown as a compensation mechanism to prohibit extensive inflammation and assist in wound healing. In cancers, the M1-like TAMs predominantly exert cytotoxicity effect on cancer cells, while the M2-like TAMs assist in modulating immunosuppressive and pro-tumoral TME for cancer progression. Nowadays, TAMs are becoming promising targets for therapeutic strategies [61, 62]. Many Chinese herbal medicines have been identified to have anti-microbial, anti-inflammatory, immune regulatory, and antitumor effects. It would be interesting to review the intervention of Chinese medicines on TAM polarization in different cancers and diseases. Here, we select some of the Chinese medicines to describe as examples.
3.1 Baicalein
Baicalein (5,6,7-trihydroxyflavone) is isolated from the Chinese herb
3.2 Panax notoginseng
The root of
3.3 Osthole
Osthole [7-methoxy-8-(3-methyl-2-butenyl)-2H-1-benzopyran-2-one] is isolated from
3.4 Emodin
Emodin (1,3,8-trihydroxy-6-methylanthraquinone) is a natural anthraquinone derivative from many Chinese herbs, and it has multiple pharmacological effects [75]. One study focused on the effects of emodin on macrophage polarization has shown that it could bidirectionally regulate both M1 and M2 phenotype programs via different signaling pathways, as well as participated in the epigenetic modification. It seems like that emodin can restrain excessive M1- or M2-like macrophages and assist in maintaining homeostasis in different pathologies. For example, in breast cancer, emodin decreased TAM infiltration and inhibited M2-polarized phenotype by suppressing STAT6 and C/EBPβ signaling pathway. Moreover, it could increase H3K27m3 to downregulate M2-related genes.
3.5 Other Chinese medicine
Many other Chinese medicines have protective functions on different diseases through regulating M1/M2 phenotypic switch (as shown in Table 1). For example, curcumin can promote macrophages toward M2-like phenotype to ameliorate liver fibrosis, and it also assists wound healing [76]. Smiglaside A and Ginsenoside Rb3 have protective functions against acute lung injury via inducing M2-like macrophage polarization [77, 78]. These findings may throw a new light for the regulatory mechanisms of Chinese medicines and promote their applications in health and diseases.
Chinese medicine | M1/M2 phenotype switch | Disease | Reference |
---|---|---|---|
M2 | Cardiac fibrosis | [79] | |
Baicalein | M1 | Breast cancer | [65] |
Berberine | M2 | Colitis; insulin resistance | [80, 81] |
Bergenin | M2 | Colitis | [82] |
Celastrol | M2 | Diet-induced obesity; acute ischemic stroke | [83, 84] |
Corilagin | M1 | Schistosome egg-induced hepatic fibrosis | [85] |
Crocin | M2 | Atherosclerosis | [86] |
Curcumin | M2 | Liver fibrosis; wound healing | [76, 87] |
Dioscin | M1 | Melanoma | [88] |
Diosgenin glucoside | M2 | Neuroinflammatory diseases | [89] |
Emodin | M1 | Breast cancer | [90] |
M1 | Inflammation | [91] | |
Gastrodin | M2 | Cerebral palsy | [92] |
Ginkgolide B | M2 | Ischemic stroke | [93] |
Ginsenoside Rb1 | M2 | Atherosclerosis | [94] |
Ginsenoside Rb3 | M2 | Acute lung injury | [78] |
Isoliquiritigenin | M2 | Acute kidney injury | [95] |
Kumatakenin | M1 | Ovarian cancer | [96] |
Magnesium lithospermate B | M2 | Neuronal injury | [97] |
M1 | Lung carcinoma | [98] | |
Osthole | M1 | Pancreatic cancer | [74] |
Paeoniflorin | M2 | Neuronal injury | [99] |
M1 | Lung carcinoma; influenza A virus infection | [69, 100] | |
Pentacyclic triterpene Lupeol | M2 | Inflammatory bowel disease | [101] |
Pterostilbene | M1 | Lung cancer | [102] |
Punicalagin | M2 | Inflammation | [103] |
Saponin | M2 | Intestinal polyps | [104] |
Smiglaside A | M2 | Acute lung injury | [77] |
Tanshinone IIA | M2 | Acute kidney injury Inflammation | [105] |
Timosaponin AIII | M2 | Colitis | [106] |
M2 | Streptozocin-induced kidney injury | [107] |
4. Conclusions
Current studies have described the heterogeneity and adaptive plasticity of TAMs in the intrinsic and dynamic TME. They are composed of both tissue-resident macrophages and monocyte-derived macrophages and interplay with TME. The latter one is attracted and recruited to the tumor site via various signals in TME, while TAMs can produce different molecules to remodel TME. In response to different stimuli, TAMs can differentiate into either classically activated/M1 macrophages or alternatively activated/M2 macrophage which involves multiple signaling pathways. The role of TAMs depends on their dichotomic polarization in health and disease. Therefore, they are becoming potential targets for many therapeutic strategies. Chinese medicine has been widely used in a long history of Asia and shows multiple effects on different diseases. Knowing the intervention of Chinese medicine on TAMs polarization may help to better understand the principle of Chinese medicine and contribute to the comprehensive applications in many diseases.
Acknowledgments
The study was financially supported by grants from the research council of the University of Hong Kong (Project Codes: 104004092, 104004460, 104004746); the Research Grants Committee (RGC) of Hong Kong, HKSAR (Project Codes: 764708, 766211, 17152116); Wong’s Donation on Modern Oncology of Chinese Medicine (Project code: 200006276); Gala Family Trust (Project Code: 200007008); and Innovation Technology Fund of Hong Kong (ITF. Project code: 260900263).
Abbreviations
AP-1 | activator protein 1 |
ARG1 | arginase-1 |
ATM | adipose tissue macrophage |
CCR | C-C motif chemokine receptors |
CSF1 | colony stimulating factor |
DLL | Delta-like protein |
EGF | endothelial growth factor |
FcR | Fc receptor |
FOXO1 | Forkhead Box O1 |
GPCR | G-protein-coupled receptors |
HFD | high-fat diet |
HIF | hypoxia inducible factor |
IFN | interferon |
IL | interleukin |
iNOS | inducible nitric oxide synthase |
IRF | interferon regulatory factor |
JAK | Janus kinase |
JNK | c-Jun N-terminal kinase |
LPS | lipopolysaccharide |
MAM | metastatic-associated macrophage |
MAPK | mitogen-activated protein kinase |
MMP | metalloprotease |
mTOR | mammalian target of rapamycin |
NAFLD | nonalcoholic fatty liver disease |
NICD | intracellular domain of notch receptor |
NPC | nasopharyngeal cancer |
PDGF | platelet-derived growth factor |
PI3K | phosphoinositide-3-kinase |
PIP2 | phosphatidylinositol 4,5-bisphosphate |
PIP3 | phosphatidylinositol 3,4,5-trisphosphate |
PN | Panax notoginseng |
PPAR | peroxisome proliferator-activated receptor |
PRR | pattern recognition receptor |
RBP-J | recombination signal binding protein for immunoglobulin Kappa J region |
ROS | reactive oxygen species |
Smad3 | SMAD family member 3 |
SOCS | suppressor of cytokine signaling |
STAT | signal transducer and activator of transcription |
TAM | tumor-associated macrophages |
TGF | transforming growth factor |
Th1 | type 1 T helper |
Th2 | type 2 T helper |
TLR | Toll-like receptor |
TME | tumor microenvironment |
TRAF | TNF receptor-associated factor |
VEGF | vascular endothelial growth factor |
Ym1 | chitinase-like 3 |
References
- 1.
Alamoud KA, Kukuruzinska MA. Emerging insights into Wnt/β-catenin signalling in head and neck cancer. Journal of Dental Research. 2018; 97 (6):665-673 - 2.
Noy R, Pollard JWJI. Tumor-associated macrophages: From mechanisms to therapy. Immunity. 2014; 41 (1):49-61 - 3.
Zhang QW et al. Prognostic significance of tumor-associated macrophages in solid tumor: A meta-analysis of the literature. Plos One. 2012; 7 (12):e50946 - 4.
Guo B et al. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma. BMC Medicine. 2016; 14 (1):159 - 5.
Mei J et al. Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis. Oncotarget. 2016; 7 (23):34217 - 6.
Yin S et al. The prognostic and clinicopathological significance of tumor-associated macrophages in patients with gastric cancer: A meta-analysis. PloS One. 2017; 12 (1):e0170042 - 7.
Nakatsumi H, Matsumoto M, Nakayama KI. Noncanonical pathway for regulation of CCL2 expression by an mTORC1-FOXK1 axis promotes recruitment of tumor-associated macrophages. Cell Reports. 2017; 21 (9):2471-2486 - 8.
Qian BZ et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011; 475 (7355):222 - 9.
Halama N et al. Tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients. Cancer Cell. 2016; 29 (4):587-601 - 10.
Abraham D et al. Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma. International Journal of Cancer. 2010; 126 (6):1339-1352 - 11.
Leung SY et al. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathologica. 1997; 93 (5):518-527 - 12.
Negus R et al. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of CC chemokines. The American Journal of Pathology. 1997; 150 (5):1723 - 13.
Arenberg DA et al. Macrophage infiltration in human non-small-cell lung cancer: The role of CC chemokines. Cancer Immunology, Immunotherapy. 2000; 49 (2):63-70 - 14.
Ueno T et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clinical Cancer Research. 2000; 6 (8):3282-3289 - 15.
Ohta M et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. International Journal of Cancer. 2002; 102 (3):220-224. DOI: 10.1002/ijc.10705 - 16.
Pena CG et al. LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment. The Journal of Clinical Investigation. 2015; 125 (11):4063-4076. DOI: 10.1172/JCI82152 - 17.
Arakaki R et al. CCL2 as a potential therapeutic target for clear cell renal cell carcinoma. Cancer Medicine. 2016; 5 (10):2920-2933 - 18.
Peña CG et al. LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment. The Journal of Clinical Investigation. 2015; 125 (11):4063-4076 - 19.
Liu B et al. ATF4 regulates CCL2 expression to promote endometrial cancer growth by controlling macrophage infiltration. Experimental Cell Research. 2017; 360 (2):105-112 - 20.
Fujimoto H et al. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. International Journal of Cancer. 2009; 125 (6):1276-1284 - 21.
Yoshimura T et al. Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PloS One. 2013; 8 (3):e58791 - 22.
O'sullivan C, Lewis CE, Harris ALJTL. Secretion of epidermal growth factor by macrophages associated with breast carcinoma. The Lancet. 1993; 342 (8864):148-149 - 23.
Shojaei F et al. Role of myeloid cells in tumor angiogenesis and growth. Trends in Cell Biology. 2008; 18 (8):372-378 - 24.
Kessenbrock K, Plaks V, Werb ZJC. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell. 2010; 141 (1):52-67 - 25.
Mantovani A, Sica A. Macrophages, innate immunity and cancer: Balance, tolerance, and diversity. Current Opinion in Immunology. 2010; 22 (2):231-237 - 26.
Cortez-Retamozo V et al. Origins of tumor-associated macrophages and neutrophils. Proceedings of the National Academy of Sciences. 2012; 109 (7):2491-2496 - 27.
Franklin RA et al. The cellular and molecular origin of tumor-associated macrophages. Science. 2014; 344 (6186):921-925 - 28.
van de Laar L et al. Yolk sac macrophages, fetal liver, and adult monocytes can colonize an empty niche and develop into functional tissue-resident macrophages. Immunity. 2016; 44 (4):755-768 - 29.
Mantovani A et al. Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology. 2002; 23 (11):549-555 - 30.
Gordon S. Alternative activation of macrophages. Nature Reviews Immunology. 2003; 3 (1):23 - 31.
Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nature Reviews Immunology. 2005; 5 (12):953 - 32.
Mantovani A, Sica A, Locati MJI. Macrophage polarization comes of age. Immunity. 2005; 23 (4):344-346 - 33.
Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: An immunologic functional perspective. Annual Review of Immunology. 2009; 27 :451-483 - 34.
Rhee I. Diverse macrophages polarization in tumor microenvironment. Archives of Pharmacal Research. 2016; 39 (11):1588-1596 - 35.
Mantovani A, Sica A, Locati M. New vistas on macrophage differentiation and activation. European Journal of Immunology. 2007; 37 (1):14-16 - 36.
Yeung OW et al. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. Journal of Hepatology. 2015; 62 (3):607-616 - 37.
Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nature Immunology. 2010; 11 (10):889 - 38.
Mantovani A et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology. 2004; 25 (12):677-686 - 39.
Kumar A et al. JNK pathway signalling: A novel and smarter therapeutic targets for various biological diseases. Future Medicinal Chemistry. 2015; 7 (15):2065-2086 - 40.
Zhou D et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signalling pathways. Cellular Signalling. 2014; 26 (2):192-197 - 41.
Weisberg SP et al. Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation. 2003; 112 (12):1796-1808 - 42.
Luyendyk JP et al. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. The Journal of Immunology. 2008; 180 (6):4218-4226 - 43.
Lancaster GI, Febbraio MA. The immunomodulating role of exercise in metabolic disease[J]. Trends in Immunology, 2014; 35 (6):262-269 - 44.
Covarrubias AJ, Aksoylar HI, Horng T. Control of macrophage metabolism and activation by mTOR and Akt signalling. Seminars in Immunology. Elsevier: Academic Press; 2015; 27 (4):286-296 - 45.
Fukao T, Koyasu S. PI3K and negative regulation of TLR signalling. Trends in Immunology. 2003; 24 (7):358-363 - 46.
Troutman TD, Bazan JF, Pasare C. Toll-like receptors, signalling adapters and regulation of the pro-inflammatory response by PI3K. Cell Cycle. 2012; 11 (19):3559-3567 - 47.
Polumuri SK, Toshchakov VY, Vogel SN. Role of phosphatidylinositol-3 kinase in transcriptional regulation of TLR-induced IL-12 and IL-10 by Fcγ receptor ligation in murine macrophages. The Journal of Immunology. 2007; 179 (1):236-246 - 48.
Vergadi E et al. Akt signalling pathway in macrophage activation and M1/M2 polarization. The Journal of Immunology. 2017; 198 (3):1006-1014 - 49.
O’Shea JJ, Plenge RJI. JAK and STAT signalling molecules in immunoregulation and immune-mediated disease. Immunity. 2012; 36 (4):542-550 - 50.
Hu X et al. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. Journal of Leukocyte Biology. 2007; 82 (2):237-243 - 51.
Satoh T et al. Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. Nature. 2013; 495 (7442):524 - 52.
Bhattacharjee A et al. IL-4 and IL-13 employ discrete signalling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radical Biology and Medicine. 2013; 54 :1-16 - 53.
Qin H et al. SOCS3 deficiency promotes M1 macrophage polarization and inflammation. The Journal of Immunology. 2012; 189 (7):3439-3448 - 54.
Croker BA, Kiu H, Nicholson SE. SOCS regulation of the JAK/STAT signalling pathway. In: Seminars in Cell and Developmental Biology. Elsevier: Academic Press; 2008; 19 (4):414-422 - 55.
Kopan R, Ilagan MX. The canonical Notch signalling pathway: Unfolding the activation mechanism. Cell. 2009; 137 (2):216-233 - 56.
Fung E et al. Delta-like 4 induces notch signalling in macrophages: Implications for inflammation. Inflammation. 2007; 115 (23):2948-2956 - 57.
Liu J et al. Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. Journal of Biological Chemistry. 2004; 279 (53):55609-55617 - 58.
Porta C et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB. Proceedings of the National Academy of Sciences. 2009; 106 (35):14978-14983 - 59.
Bonizzi G, Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends in Immunology. 2004; 25 (6):280-288 - 60.
Takeda N et al. Differential activation and antagonistic function of HIF-α isoforms in macrophages are essential for NO homeostasis. Genes & Development. 2010; 24 (5):491-501 - 61.
Mantovani A, Allavena P, Sica A. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: Role in tumour progression. European Journal of Cancer. 2004; 40 (11):1660-1667 - 62.
Condeelis J, Pollard JWJC. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006; 124 (2):263-266 - 63.
Bie B et al. Baicalein, a natural anti-cancer compound, alters microRNA expression profiles in Bel-7402 human hepatocellular carcinoma cells. Cellular Physiology and Biochemistry. 2017; 41 (4):1519-1531 - 64.
Wang W et al. Baicalein attenuates renal fibrosis by inhibiting inflammation via down-regulating NF-κB and MAPK signal pathways. Journal of Molecular Histology. 2015; 46 (3):283-290 - 65.
Zhao X et al. Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarization. American Journal of Cancer Research. 2018; 8 (8):1528 - 66.
Liu J et al. Saponins of Panax notoginseng: Chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases. Expert Opinion on investigational Drugs. 2014; 23 (4):523-539 - 67.
Aplin JD. MUC-1 glycosylation in endometrium: Possible roles of the apical glycocalyx at implantation. Human Reproduction. 1999; 14 (suppl_2):17-25 - 68.
Wang CZ, Anderson S, Yuan CS. Phytochemistry and anticancer potential of notoginseng. The American Journal of Chinese Medicine. 2016; 44 (01):23-34 - 69.
Kim B et al. Panax notoginseng inhibits tumor growth through activating macrophage to M1 polarization. American Journal of Chinese Medicine. 2018; 46 (06):1369-1385. DOI: 10.1142/s0192415x18500726 - 70.
Zhang ZR et al. Osthole: A review on its bioactivities, pharmacological properties, and potential as alternative medicine. Evidence-Based Complementary and Alternative Medicine. 2015; 2015 - 71.
Lin ZK et al. Osthole inhibits the tumorigenesis of hepatocellular carcinoma cells. Oncology Reports. 2017; 37 (3):1611-1618 - 72.
Liu PY et al. Osthole induces human nasopharyngeal cancer cells apoptosis through Fas–Fas ligand and mitochondrial pathway. Environmental Toxicology. 2018; 33 (4):446-453 - 73.
Xu XM et al. Osthole suppresses migration and invasion of A549 human lung cancer cells through inhibition of matrix metalloproteinase-2 and matrix metallopeptidase-9 in vitro. Molecular Medicine Reports. 2012; 6 (5):1018-1022 - 74.
Wang B et al. Osthole inhibits pancreatic cancer progression by directly exerting negative effects on cancer cells and attenuating tumor-infiltrating M2 macrophages. Journal of Pharmacological Sciences. 2018; 137 (3):290-298. DOI: 10.1016/j.jphs.2018.07.007 - 75.
Wang JB et al. Hepatotoxicity or hepatoprotection? Pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury. PloS One. 2011;6 (9):e24498 - 76.
Zhao XA et al. Curcumin reduces Ly6C(hi) monocyte infiltration to protect against liver fibrosis by inhibiting Kupffer cells activation to reduce chemokines secretion. Biomedicine and Pharmacotherapy. 2018; 106 :868-878. DOI: 10.1016/j.biopha.2018.07.028 - 77.
Wang Y et al. Smiglaside A ameliorates LPS-induced acute lung injury by modulating macrophage polarization via AMPK-PPARgamma pathway. Biochemical Pharmacology. 2018; 156 :385-395. DOI: 10.1016/j.bcp.2018.09.002 - 78.
Yang J et al. Ginsenoside Rg3 attenuates lipopolysaccharide-induced acute lung injury via MerTK-dependent activation of the PI3K/AKT/mTOR pathway. Frontiers in Pharmacology. 2018; 9 :850. DOI: 10.3389/fphar.2018.00850 - 79.
Lee TM et al. Preconditioned adipose-derived stem cells ameliorate cardiac fibrosis by regulating macrophage polarization in infarcted rat hearts through the PI3K/STAT3 pathway. Laboratory Investigation. 2019:1 - 80.
Liu Y et al. Berberine inhibits macrophage M1 polarization via AKT1/SOCS1/NF-kappaB signalling pathway to protect against DSS-induced colitis. International Immunopharmacology. 2018; 57 :121-131. DOI: 10.1016/j.intimp.2018.01.049 - 81.
Ye L et al. Inhibition of M1 macrophage activation in adipose tissue by berberine improves insulin resistance. Life Sciences. 2016; 166 :82-91. DOI: 10.1016/j.lfs.2016.09.025 - 82.
Wang K et al. Bergenin, acting as an agonist of PPARgamma, ameliorates experimental colitis in mice through improving expression of SIRT1, and therefore inhibiting NF-kappaB-mediated macrophage activation. Frontiers in Pharmacology. 2017; 8 :981. DOI: 10.3389/fphar.2017.00981 - 83.
Luo D et al. Natural product celastrol suppressed macrophage M1 polarization against inflammation in diet-induced obese mice via regulating Nrf2/HO-1, MAP kinase and NF-kappaB pathways. Aging (Albany NY). 2017; 9 (10):2069 - 84.
Jiang M et al. Celastrol treatment protects against acute ischemic stroke-induced brain injury by promoting an IL-33/ST2 axis-mediated microglia/macrophage M2 polarization. Journal of Neuroinflammation. 2018; 15 (1):78. DOI: 10.1186/s12974-018-1124-6 - 85.
Li YQ et al. Corilagin counteracts IL-13Ralpha1 signalling pathway in macrophages to mitigate schistosome egg-induced hepatic fibrosis. Frontiers in Cellular and Infection Microbiology. 2017; 7 :443. DOI: 10.3389/fcimb.2017.00443 - 86.
Li J et al. Crocin alleviates coronary atherosclerosis via inhibiting lipid synthesis and inducing M2 macrophage polarization. International Immunopharmacology. 2018; 55 :120-127. DOI: 10.1016/j.intimp.2017.11.037 - 87.
Yang Z et al. Curcumin-mediated bone marrow mesenchymal stem cell sheets create a favorable immune microenvironment for adult full-thickness cutaneous wound healing. Stem Cell Research and Therapy. 2018; 9 (1):21. DOI: 10.1186/s13287-018-0768-6 - 88.
Kou Y et al. Connexin 43 upregulation by dioscin inhibits melanoma progression via suppressing malignancy and inducing M1 polarization. International Journal of Cancer. 2017; 141 (8):1690-1703. DOI: 10.1002/ijc.30872 - 89.
Wang S et al. Diosgenin glucoside provides neuroprotection by regulating microglial M1 polarization. International Immunopharmacology. 2017; 50 :22-29. DOI: 10.1016/j.intimp.2017.06.008 - 90.
Iwanowycz S et al. Emodin inhibits breast cancer growth by blocking the tumor-promoting feedforward loop between cancer cells and macrophages. Molecular Cancer Therapeutics. 2016; 15 (8):1931-1942. DOI: 10.1158/1535-7163.Mct-15-0987 - 91.
Sun LX et al. The improvement of M1 polarization in macrophages by glycopeptide derived from Ganoderma lucidum . Immunologic Research. 2017;65 (3):658-665. DOI: 10.1007/s12026-017-8893-3 - 92.
Jia J et al. BCL6 mediates the effects of gastrodin on promoting M2-like macrophage polarization and protecting against oxidative stress-induced apoptosis and cell death in macrophages. Biochemical and Biophysical Research Communications. 2017; 486 (2):458-464. DOI: 10.1016/j.bbrc.2017.03.062 - 93.
Shu ZM et al. Ginkgolide B protects against ischemic stroke via modulating microglia polarization in mice. CNS Neuroscience and Therapeutics. 2016; 22 (9):729-739. DOI: 10.1111/cns.12577 - 94.
Zhang X et al. Ginsenoside Rb1 enhances atherosclerotic plaque stability by skewing macrophages to the M2 phenotype. Journal of Cellular and Molecular Medicine. 2018; 22 (1):409-416. DOI: 10.1111/jcmm.13329 - 95.
Tang Y et al. Isoliquiritigenin attenuates LPS-induced AKI by suppression of inflammation involving NF-κB pathway. American Journal of Translational Research. 2018; 10 (12):4141 - 96.
Woo JH et al. Effect of kumatakenin isolated from cloves on the apoptosis of cancer cells and the alternative activation of tumor-associated macrophages. Journal of Agricultural and Food Chemistry. 2017; 65 (36):7893-7899. DOI: 10.1021/acs.jafc.7b01543 - 97.
Tai Y, Qiu Y, Bao Z. Magnesium lithospermate B suppresses lipopolysaccharide-induced neuroinflammation in BV2 microglial cells and attenuates neurodegeneration in lipopolysaccharide-injected mice. Journal of Molecular Neuroscience. 2018; 64 (1):80-92. DOI: 10.1007/s12031-017-1007-9 - 98.
Chung HS, Lee BS, Ma JY. Ethanol extract of Mylabris phalerata inhibits M2 polarization induced by recombinant IL-4 and IL-13 in murine macrophages. Evidence-based Complementary and Alternative Medicine. 2017; 2017 :4218468. DOI: 10.1155/2017/4218468 - 99.
Luo XQ et al. Paeoniflorin exerts neuroprotective effects by modulating the M1/M2 subset polarization of microglia/macrophages in the hippocampal CA1 region of vascular dementia rats via cannabinoid receptor 2. Chinese Medicine. 2018; 13 :14. DOI: 10.1186/s13020-018-0173-1 - 100.
Choi JG et al. Protective effect of panax notoginseng root water extract against influenza A virus infection by enhancing antiviral interferon-mediated immune responses and natural killer cell activity. Frontiers in Immunology. 2017; 8 :1542. DOI: 10.3389/fimmu.2017.01542 - 101.
Zhu Y et al. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease. International Immunopharmacology. 2016; 30 :74-84. DOI: 10.1016/j.intimp.2015.11.031 - 102.
Huang WC et al. Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene. Oncotarget. 2016; 7 (26):39363-39375. DOI: 10.18632/oncotarget.8101 - 103.
Xu X et al. Punicalagin, a PTP1B inhibitor, induces M2c phenotype polarization via up-regulation of HO-1 in murine macrophages. Free Radical Biology and Medicine. 2017; 110 :408-420. DOI: 10.1016/j.freeradbiomed.2017.06.014 - 104.
Chen L et al. Triterpenoid herbal saponins enhance beneficial bacteria, decrease sulfate-reducing bacteria, modulate inflammatory intestinal microenvironment and exert cancer preventive effects in ApcMin/+ mice. Oncotarget. 2016; 7 (21):31226-31242. DOI: 10.18632/oncotarget.8886 - 105.
Gao S et al. Tanshinone IIA alleviates inflammatory response and directs macrophage polarization in lipopolysaccharide-stimulated RAW264. Cell. 2018; 7 :1-12 - 106.
Lim SM et al. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-kappaB and MAPK activation and restoring Th17/Treg cell balance. International Immunopharmacology. 2015; 25 (2):493-503. DOI: 10.1016/j.intimp.2015.02.016 - 107.
Jiandong L et al. Trichosanthes kirilowii lectin ameliorates streptozocin-induced kidney injury via modulation of the balance between M1/M2 phenotype macrophage. Biomedicine and Pharmacotherapy. 2018; 109 :93-102. DOI: 10.1016/j.biopha.2018.10.060